help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 5, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-2000
A more recent version of this article appeared on July 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/7/4388    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ye, L.
Right arrow Articles by Ning, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ye, L.
Right arrow Articles by Ning, G.
Right arrowPubmed/NCBI databases
*UniSTS
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*VASOPRESSIN

Submitted on October 11, 2004
Accepted on March 29, 2005

Autosomal Dominant Neurohypophyseal Diabetes Insipidus with Linkage to Chromosome 20p13 but without Mutations in the AVP-NPII Gene

Lei Ye, Xiaoying Li, Ying Chen, Hongtao Sun, Weiqing Wang, Tingwei Su, Lei Jiang, Bin Cui, and Guang Ning*

Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Second Medical University, 197 Ruijin Er Lu, Shanghai, 200025;the Department of Internal Medicine, Inner Mongolia University for Nationalities affiliated Hospital, Inner Mongolia 028000; and the Division of Endocrine and Metabolic Diseases, E-Institute of Shanghai Universities, Shanghai 200025, P.R.China

* To whom correspondence should be addressed. E-mail: guangning{at}medmail.com.cn.

Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) is a rare disorder, transmitted as an autosomal dominant trait, characterized by polyuria and polydipsia, and caused by deficient neurosecretion of arginine vasopressin precursor (AVP-NPII). More than 40 mutations have been described since the first mutation of AVP-NPII gene was reported in 1991. We diagnosed two families with ADNDI and identified a 3 bp deletion (1827-1829delAGG) of AVP-NPII gene in one pedigree. We found no mutations in the coding, the promoter and intronic regions of AVP-NPII gene in the other ADNDI family. A genome-wide scan was performed in this family and the maximum LOD score of 1.202999({theta} = 0.00)was obtained at marker D20S889. Fine mapping localized the corresponding gene(s) in a 7 cM interval defined by D20S199-D20S849 on Chromosome 20, in which AVP-NPII gene is also located. We further sequenced the intragenic region (IGR) that regulates AVP-NPII and oxytocin expression as an enhancer element and UBCE7IP5 gene that participates in prohormone degradation, and did not detect any alterations for those candidate genes. Regarding the almost identical clinical features in these two families, the corresponding locus responsible for ADNDI is possibly heterogeneous.


Key words: Diabetes insipidus • Gene mutation • AVP-NPII • Linkage analysis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society